Search results
There’s a problem that caused one batch of insulin injection pens to be recalled
Miami Herald via AOL· 2 years agoMylan Pharmaceuticals recalled one batch of Insulin Glargine Injection, 100 units/mL (U-100), 3 mL...
25 Biggest Pharmaceutical Companies in the World A Year Ago
Insider Monkey via Yahoo Finance· 2 years agoIn this article we listed the 25 biggest pharmaceutical companies in the world a year ago and then...
US Patent Office won't review two Novo Nordisk patents for Wegovy, Ozempic
Reuters via Yahoo Finance· 7 months agoA U.S. Patent Office tribunal on Monday rejected challenges to two key patents owned by Novo Nordisk...
The Viatris Inc (VTRS) Company: A Short SWOT Analysis
GuruFocus.com via Yahoo Finance· 6 months agoStrengths: Viatris Inc's expansive global presence and diversified portfolio position it as a leader...
U.S. Supreme Court turns away Biogen bid to reinstate MS drug patent
Reuters via Yahoo News· 2 years agoWASHINGTON (Reuters) -The U.S. Supreme Court on Monday declined to hear Biogen Inc's bid to win...
Unveiling Viatris (VTRS)'s Value: Is It Really Priced Right? A Comprehensive Guide
GuruFocus.com via Yahoo Finance· 8 months agoViatris Inc (NASDAQ:VTRS), a pharmaceutical giant formed through the merger of Upjohn and Mylan,...
US Supreme Court spurns Sanofi appeal to revive EpiPen suit against Viatris
Reuters via Yahoo Finance· 1 year agoWASHINGTON (Reuters) -The U.S. Supreme Court on Monday declined to hear a bid by Sanofi SA to revive...
Manchin, daughter pitching donors on a centrist group, source says
CBS News via Yahoo News· 8 months agoDemocratic Sen. Joe Manchin of West Virginia and his daughter, former pharmaceutical executive...
Here's How Much a $1000 Investment in Abbott Made 10 Years Ago Would Be Worth Today
Zacks via Yahoo Finance· 10 months agoFor most investors, how much a stock's price changes over time is important. Not only can it impact...
Merck wins ruling upholding diabetes-treatment patent at U.S. appeals court
Reuters via Yahoo Finance· 2 years agoA Merck Sharp & Dohme Corp patent related to its diabetes drugs Januvia and Janumet is valid, a U.S. appeals court said Thursday, rejecting a challenge to the patent by generic drugmaker Mylan ...